Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2015, Vol. 9 Issue (4) : 437-443    https://doi.org/10.1007/s11684-015-0422-y
RESEARCH ARTICLE
Outcome of Stretta radiofrequency and fundoplication for GERD-related severe asthmatic symptoms
Zhiwei Hu,Jimin Wu,Zhonggao Wang(),Yu Zhang,Weitao Liang,Chao Yan
Department of Gastroesophageal Reflux Disease, the Second Artillery General Hospital PLA, Beijing 100088, China
 Download: PDF(179 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

This study aimed to investigate the outcome of treatment with Stretta radiofrequency (SRF) or laparoscopic Nissen fundoplication (LNF). A total of 137 gastroesophageal reflux disease (GERD) patients with severe asthmatic symptoms who responded inadequately to medical treatment for asthma were investigated. The patients were followed up 1 year and 5 years after SRF (n = 82) or LNF (n = 55) treatment. A questionnaire covering 29 related symptoms and medication use was employed. Digestive, respiratory, and ear-nose-throat (ENT) symptom scores significantly decreased after antireflux treatment. Symptom scores respectively changed from 17.2±10.1, 31.9±6.6, and 21.1±11.8 to 5.0±6.2, 11.5±10.2, and 6.3±6.8 at 1 year and to 5.6±6.5, 13.1±10.1, and 7.8±7.2 at 5 years (P <0.001). The outcome of LNF was significantly better than that of SRF in terms of digestive (P <0.001, P = 0.001), respiratory (P = 0.006, P = 0.001), and ENT symptoms (P = 0.006, P = 0.003) at both 1 year and 5 years. SRF and LNF were both effective against the digestive symptoms of GERD as well as GERD-related severe asthmatic and ENT symptoms, with better outcomes exhibited by the LNF group. Severe asthmatic symptoms and GERD were closely associated, and this finding warrants further study.

Keywords asthma      gastroesophageal reflux      Stretta radiofrequency      laparoscopic Nissen fundoplication     
Corresponding Author(s): Zhonggao Wang   
Just Accepted Date: 09 November 2015   Online First Date: 17 November 2015    Issue Date: 26 November 2015
 Cite this article:   
Zhiwei Hu,Jimin Wu,Zhonggao Wang, et al. Outcome of Stretta radiofrequency and fundoplication for GERD-related severe asthmatic symptoms[J]. Front. Med., 2015, 9(4): 437-443.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-015-0422-y
https://academic.hep.com.cn/fmd/EN/Y2015/V9/I4/437
Frequency of symptoms Severity of symptoms Score
No symptoms No symptoms 0
Less than once per week Slight symptoms 1
Once or twice per week Mild symptoms, uncomfortable but do not affect normal life 2
Three or four times per week Moderate symptoms that affect normal life and work 3
Five or six times per week Severe symptoms, very uncomfortable, partially incapacitating 4
More than six times per week Very severe symptoms, incapacitating or life-threatening, even requiring one or more rescue processes 5
Tab.1  Symptom frequency and severity scores
Characteristic/parameter SRF (n = 82) LNF (n = 55)
Male/female 33/49 27/28
Age (year) 49.1 (20–74) 48.2 (29–69)
Smoker/nonsmoker 7/65 6/49
Lung function tests n = 76 n = 49
FEV1, L (% predicted) 1.59±0.8 (63.5±23.8) 1.59±0.8 (60.1±26.8)
FEF, L/s (% predicted) 4.6±2.7 (67.1±25.3) 4.6±2.7 (70.0±29.2)
FEV1/FVC<70% 37 (45.1%) 23 (41.8%)
Endoscopy n = 72 n = 29
Esophagitis 14 (19.4%) 14 (48.3%)
LA-A 7 (9.7%) 7 (23.3%)
LA-B 5 (6.9%) 6 (20.0%)
LA-C 1 (1.4%) 1 (3.3%)
LA-D 0 (0%) 1 (3.3%)
Barrett esophagus 1 (1.4%) 0 (0%)
Hiatus hernia 0 12
Dual 24-h pH monitoring n = 67 n = 37
DMS (distal channel) 29.48±48.25 46.60±57.16
DMS>14.72 (distal channel) 37 (55.2%) 28 (75.7%)
DMS (proximal channel) 15.65±34.39 7.90±6.99
Esophageal manometry n = 64 n = 41
MUESP, mmHg (P%) 34.5±16.6 (50.0) 34.6±19.3 (56.1)
MLESP, mmHg (P%) 18.0±6.5 (18.8) 16.5±7.1 (31.7)
LHPZ, cm (P%) 3.2±3.8 (42.2) 2.8±0.6 (39.0)
Esophageal hypotonia, P% 45.3 51.2
Tab.2  Patient demographics and characteristics
Symptoms in questionnaire n (%) Symptom score (1 year) P value Symptom score (5 years) P value
Pre-treatment Post-treatment Pre-treatment Post-treatment
Acid regurgitation 111 (81.0%) 4.1±1.7 0.8±1.3 <0.001 4.1±1.7 1.0±1.4 <0.001
Food regurgitation 59 (43.1%) 3.4±1.7 0.6±1.1 <0.001 3.4±1.7 0.8±1.2 <0.001
Heartburn 101 (73.7%) 4.3±1.7 0.8±1.4 <0.001 4.3±1.7 1.1±1.5 <0.001
Chest pain 55 (40.1%) 4.1±1.7 1.4±1.7 <0.001 4.1±1.7 1.4±1.4 <0.001
Back pain 48 (35.0%) 4.4±1.9 1.6±1.9 <0.001 4.4±1.9 1.6±1.7 <0.001
Belching 57 (41.6%) 3.5±1.7 1.4±1.7 <0.001 3.5±1.7 1.5±1.5 <0.001
Hiccups 20 (14.6%) 4.4±2.0 1.5±2.0 <0.001 4.4±2.0 1.8±2.0 <0.001
Bloating 91 (66.4%) 4.6±1.8 1.8±2.0 <0.001 4.6±1.8 2.0±1.9 <0.001
Epigastric pain 19 (13.9%) 3.6±1.7 1.1±1.9 <0.001 3.6±1.7 1.2±1.7 <0.001
Digestive symptoms 133 (97.1%) 17.2±10.1 5.0±6.2 <0.001 17.2±10.1 5.6±6.5 <0.001
Cough 131 (89.1%) 7.0±1.7 2.4±2.5 <0.001 7.0±1.7 2.8±2.5 <0.001
Wheezing 137 (100%) 6.5±1.7 2.7±2.5 <0.001 6.5±1.7 2.9±2.4 <0.001
Chest tightness 122 (89.1%) 8.6±1.2 3.2±2.9 <0.001 8.6±1.2 3.5±2.8 <0.001
Expectoration 115 (83.9%) 8.4±1.5 2.9±2.9 <0.001 8.4±1.5 3.4±2.6 <0.001
Choking 25 (18.2%) 5.9±2.1 1.3±2.0 <0.001 5.9±2.1 1.8±1.9 <0.001
Shortness of breath 52 (38.0%) 7.0±1.9 2.8±2.9 <0.001 7.0±1.9 3.2±2.8 <0.001
Respiratory symptoms 137 (100%) 31.9±6.6 11.5±10.2 <0.001 31.9±6.6 13.1±10.1 <0.001
Earache 31 (22.6%) 3.9±1.8 1.2±2.0 <0.001 3.9±1.8 1.5±1.8 <0.001
Tinnitus 43 (31.4%) 3.5±1.6 1.5±1.8 <0.001 3.5±1.6 1.6±1.8 <0.001
Impaired hearing 31 (22.6%) 4.0±2.2 1.9±2.2 <0.001 4.0±2.2 2.2±2.2 <0.001
Nasal discharge 70 (51.1%) 4.5±1.7 1.6±1.9 <0.001 4.5±1.7 1.9±1.9 <0.001
Postnasal drip 9 (6.6%) 2.9±1.1 0.4±0.9 0.002 2.9±1.1 1.2±0.9 0.008
Nasal obstruction 52 (38.0%) 3.9±1.6 1.8±2.0 <0.001 3.9±1.6 2.0±1.9 <0.001
Sneezing 60 (43.8%) 4.0±1.8 1.6±1.9 <0.001 4.0±1.8 1.9±1.9 <0.001
Snoring 32 (23.4%) 3.7±1.4 1.3±1.9 <0.001 3.7±1.4 1.4±1.8 <0.001
Throat pain 37 (27.0%) 3.7±1.6 1.1±1.7 <0.001 3.7±1.6 1.3±1.7 <0.001
Globus sensation 66 (48.2%) 4.3±1.4 1.1±1.6 <0.001 4.3±1.4 1.5±1.3 <0.001
Throat clearing 27 (19.7%) 3.9±1.6 1.0±1.3 <0.001 3.9±1.6 1.4±1.2 <0.001
Throat tightness 76 (55.5%) 5.8±2.1 0.8±1.3 <0.001 5.8±2.1 1.1±1.3 <0.001
Throat itching 57 (41.6%) 4.1±1.3 1.0±1.4 <0.001 4.1±1.3 1.4±1.3 <0.001
Chronic hoarseness 31 (22.6%) 3.4±1.5 0.8±1.4 <0.001 3.4±1.5 0.9±1.2 <0.001
ENT symptoms 124 (90.5%) 21.1±11.8 6.3±6.8 <0.001 21.1±11.8 7.8±7.2 <0.001
Tab.3  Outcome of antireflux therapy over 12 months in terms of digestive, respiratory, and ENT symptoms
Fig.1  Comparison of the outcomes of different years and methods. (A and B) Percentage symptom score reduction was better 1 year after treatment than 5 years after treatment. (C and D) Notably better results were achieved in patients treated with LNF compared with SRF in terms of digestive, respiratory, and ENT symptoms. *P<0.05; **P<0.005.
1 Vakil  N, van Zanten  SV, Kahrilas  P, Dent  J, Jones  R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol  2006; 101(8): 1900–1920, quiz 1943
https://doi.org/10.1111/j.1572-0241.2006.00630.x pmid: 16928254
2 Goh  KL. Gastroesophageal reflux disease in Asia: a historical perspective and present challenges. J Gastroenterol Hepatol  2011; 26(Suppl 1): 2–10
https://doi.org/10.1111/j.1440-1746.2010.06534.x pmid: 21199509
3 Havemann  BD, Henderson  CA, El-Serag  HB. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut  2007; 56(12): 1654–1664
https://doi.org/10.1136/gut.2007.122465 pmid: 17682001
4 Katz  PO, Gerson  LB, Vela  MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol  2013; 108(3): 308–328, quiz 329
https://doi.org/10.1038/ajg.2012.444 pmid: 23419381
5 Wang  ZG. It is gastroesophageal reflux disease, not asthma: a case report. Chin Med Sci J  2006; 21(3): 189–193
pmid: 17086743
6 Wang  Z, Kotwal  RM. Is GERD-induced asthma a different disease entity?  Ther Adv Respir Dis  2012; 6(1): 57
https://doi.org/10.1177/1753465811426446 pmid: 22013159
7 Wang  ZG, Hu  ZW, Wu  JM, Liu  JJ, Tian  SR, Ji  F, Li  ZT. The interventional treatment on extra-esophageal symptoms: preliminary experience on 2016 patients. In: Proceedings of the J Gastroen Hepatol. Hoboken: Wiley-Blackwell, 2013: 305
8 Fass  R, Fennerty  MB, Johnson  C, Camargo  L, Sampliner  RE. Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease. J Clin Gastroenterol  1999; 28(1): 36–39
https://doi.org/10.1097/00004836-199901000-00008 pmid: 9916663
9 Gao  X, Wang  ZG, Wu  JM, Ji  F, Zhang  CC, Ning  YC, Li  ZT, Hu  ZW, Chen  X, Tian  SR. Radiofrequency treatment on respiratory symptoms due to gastroesophageal reflux disease. Chin Med J (Engl) 2011; 124(7): 1006–1009
pmid: 21542958
10 Wang  ZG, Ji  F, Wu  JM, Lai  YG, Gao  X, Zhang  CC. Effect of laparoscopic fundoplication treatment on gastroesophageal reflux disease-related respiratory symptoms. Front Med China  2010; 4: 254–258
11 Zhang  C, Wang  ZG, Wu  JM, Lai  Y, Ji  F, Gao  X, Hu  Z, Zhu  G, Ning  Y, Li  Z, Liu  H, Zhao  J. A preliminary investigation of laparoscopic fundoplication treatment on gastroesophageal reflux disease-related respiratory symptoms. Surg Laparosc Endosc Percutan Tech  2012; 22(5): 406–409
https://doi.org/10.1097/SLE.0b013e3182628913 pmid: 23047382
12 Wang  ZG, Wu  JM, Liu  JJ, Wang  LY, Lai  YG, Ibrahim  IM, Wang  XJ, Dardik  H. Respiratory distress resulting from gastroesophageal reflux is not asthma, but laryngotracheal irritation, spasm, even suffocation. Chin Med Sci J  2009; 24(2): 130–132
https://doi.org/10.1016/S1001-9294(09)60076-6 pmid: 19618613
13 Sacco  O, Silvestri  M, Sabatini  F, Sale  R, Moscato  G, Pignatti  P, Mattioli  G, Rossi  GA. IL-8 and airway neutrophilia in children with gastroesophageal reflux and asthma-like symptoms. Respir Med  2006; 100(2): 307–315
https://doi.org/10.1016/j.rmed.2005.05.011 pmid: 16002270
14 Zhu  GC, Gao  X, Wang  ZG, Hu  ZW, Zhang  CC, Lai  YG, Ji  F, Wu  JM. Experimental study for the mechanism of gastroesophageal-reflux-associated asthma. Dis Esophagus  2014; 27(4): 318–324
https://doi.org/10.1111/dote.12108 pmid: 24007598
15 Rosztóczy  A, Makk  L, Izbéki  F, Róka  R, Somfay  A, Wittmann  T. Asthma and gastroesophageal reflux: clinical evaluation of esophago-bronchial reflex and proximal reflux. Digestion  2008; 77(3-4): 218–224
https://doi.org/10.1159/000146083 pmid: 18635940
16 Melvin  WS. Modern treatment for gastroesophageal reflux disease: surgery vs medication. Arch Surg  2011; 146(9): 1093–1094
https://doi.org/10.1001/archsurg.2011.202 pmid: 21931005
17 McCallister  JW, Parsons  JP, Mastronarde  JG. The relationship between gastroesophageal reflux and asthma: an update. Ther Adv Respir Dis  2011; 5(2): 143–150
https://doi.org/10.1177/1753465810384606 pmid: 20926507
18 DeMeester  TR, Bonavina  L, Albertucci  M. Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg  1986; 204(1): 9–20
https://doi.org/10.1097/00000658-198607000-00002 pmid: 3729589
19 Perrin-Fayolle  M, Gormand  F, Braillon  G, Lombard-Platet  R, Vignal  J, Azzar  D, Forichon  J, Adeleine  P. Long-term results of surgical treatment for gastroesophageal reflux in asthmatic patients. Chest  1989; 96(1): 40–45
https://doi.org/10.1378/chest.96.1.40 pmid: 2736991
20 Field  SK, Gelfand  GA, McFadden  SD. The effects of antireflux surgery on asthmatics with gastroesophageal reflux. Chest  1999; 116(3): 766–774
https://doi.org/10.1378/chest.116.3.766 pmid: 10492285
21 McCormick  DG. Stretta procedure for the treatment of gastroesophageal reflux disease. Gastroenterol Nurs  2004; 27(1): 22–28, quiz 29–30
https://doi.org/10.1097/00001610-200401000-00006 pmid: 15075961
22 Wang  ZG, Liu  JJ, Chen  X, Wu  JM, Wang  LY, Gong  Y, Bai  J, Dong  YY, Hu  YH, Lai  YG. Discovery of gastroesophago-larygotracheal syndrome (GELTS)—summing-up on treating 200 GERD patients with Stretta radiofrequency. Clin Misdiagnosis Mistherapy  2007; 20(5): 1–4,99 (in Chinese)
23 von Mutius  E, Drazen  JM. A patient with asthma seeks medical advice in 1828, 1928, and 2012. N Engl J Med  2012; 366(9): 827–834
https://doi.org/10.1056/NEJMra1102783 pmid: 22375974
24 Comay  D, Adam  V, da Silveira  EB, Kennedy  W, Mayrand  S, Barkun  AN. The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a cost-effectiveness analysis. Can J Gastroenterol  2008; 22(6): 552–558
pmid: 18560633
25 Liang  WT, Wu  JM, Hu  ZW, Wang  ZG, Zhu  GC, Zhang  C. Laparoscopic Nissen fundoplication is more effective in treating patients with GERD-related chronic cough than Stretta radiofrequency. Minerva Chir  2014; 69(3): 121–127
pmid: 24970301
26 Wang  VS, Feldman  N, Maurer  R, Burakoff  R. Esophageal motility in nonacid reflux compared with acid reflux. Dig Dis Sci  2009; 54(9): 1926–1932
https://doi.org/10.1007/s10620-008-0580-8 pmid: 19051027
27 Mainie  I, Tutuian  R, Shay  S, Vela  M, Zhang  X, Sifrim  D, Castell  DO. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut  2006; 55(10): 1398–1402
https://doi.org/10.1136/gut.2005.087668 pmid: 16556669
28 del Genio  G, Tolone  S, del Genio  F, Rossetti  G, Brusciano  L, Pizza  F, Fei  L, del Genio  A. Total fundoplication controls acid and nonacid reflux: evaluation by pre- and postoperative 24-h pH-multichannel intraluminal impedance. Surg Endosc  2008; 22(11): 2518–2523
https://doi.org/10.1007/s00464-008-9958-0 pmid: 18478292
29 Harding  SM, Guzzo  MR, Richter  JE. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med  2000; 162(1): 34–39
https://doi.org/10.1164/ajrccm.162.1.9907072 pmid: 10903216
30 Kiljander TO, Laitinen JO. The prevalence of gastroesophageal reflux disease in adult asthmatics.Chest 2004; 126(5): 1490–1494 
https://doi.org/10.1378/chest.126.5.1490 pmid: 15539717
[1] Siyi Li, Peilin Lv, Min He, Wenjing Zhang, Jieke Liu, Yao Gong, Ting Wang, Qiyong Gong, Yulin Ji, Su Lui. Cerebral regional and network characteristics in asthma patients: a resting-state fMRI study[J]. Front. Med., 2020, 14(6): 792-801.
[2] Ting Liu, Faping Wang, Geng Wang, Hui Mao. Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled trials[J]. Front. Med., 2018, 12(3): 340-349.
[3] Zhiwei Hu,Meiping Chen,Jimin Wu,Qing Song,Chao Yan,Xing Du,Zhonggao Wang. Improved control of hypertension following laparoscopic fundoplication for gastroesophageal reflux disease[J]. Front. Med., 2017, 11(1): 68-73.
[4] Fatemeh Mehravar,Soheil Rafiee,Behnaz Bazrafshan,Mahmoud Khodadost. Prevalence of asthma symptoms in Golestan schoolchildren aged 6–7 and 13–14 years in Northeast Iran[J]. Front. Med., 2016, 10(3): 345-350.
[5] Zhonggao Wang,Zhiwei Hu,Jimin Wu,Feng Ji,Hongtao Wang,Yungang Lai,Xiang Gao,Yachan Ning,Chengchao Zhang,Zhitong Li,Weitao Liang,Jianjun Liu. Insult of gastroesophageal reflux on airway: clinical significance of pharyngeal nozzle[J]. Front. Med., 2015, 9(1): 117-122.
[6] Zhong-Gao WANG MD, FACS, Feng JI MD, PhD, Yun-Gang LAI MD, PhD, Xiang GAO MD, PhD, Cheng-Chao ZHANG MD, PhD, Ji-Min WU MD, PhD, Xiu CHEN MD, PhD, Ibrahim M. IBRAHIM MD, FACS, . Effect of laparoscopic fundoplication treatment on gastroesophageal reflux disease-related respiratory symptoms[J]. Front. Med., 2010, 4(2): 254-258.
[7] Xiaoxia LU, Weikun HU, Shengdao XIONG, Guopeng XU, Fen LAN. Tim-3 mRNA expression in peripheral blood lymphocytes from asthmatic patients[J]. Front Med Chin, 2009, 3(2): 187-190.
[8] WANG Zhonggao. A belated revelation: from gastroesophageal reflux derived asthma to laryngotracheal irritation even spasm[J]. Front. Med., 2008, 2(2): 127-129.
[9] WANG Zhonggao. Not asthma, but GERD: case report[J]. Front. Med., 2007, 1(1): 115-119.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed